Expression, bioactivity, and safety 1 year after adeno-associated viral vector type 2-mediated delivery of neurturin to the monkey nigrostriatal system support cere-120 for Parkinson's disease. [electronic resource]
Producer: 20090723Description: 602-12; discussion 612-3 p. digitalISSN:- 1524-4040
- Animals
- Antigens, CD -- metabolism
- Antigens, Differentiation, Myelomonocytic -- metabolism
- Behavior, Animal -- drug effects
- Body Weight -- drug effects
- Brain -- metabolism
- Calcitonin Gene-Related Peptide -- metabolism
- Cell Count
- Corpus Striatum -- drug effects
- Dependovirus -- genetics
- Dose-Response Relationship, Drug
- Eating -- drug effects
- Enzyme-Linked Immunosorbent Assay -- methods
- Extracellular Signal-Regulated MAP Kinases -- metabolism
- Gene Expression -- physiology
- Gene Transfer Techniques
- Genetic Vectors
- Humans
- Longitudinal Studies
- Macaca mulatta
- Neurturin -- administration & dosage
- Parkinson Disease -- drug therapy
- Spinal Cord -- metabolism
- Time Factors
- Tissue Distribution
- Tyrosine 3-Monooxygenase -- metabolism
- Viral Matrix Proteins -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.